Glucagon Like Peptide-1 (GLP-1) Agonists Market - Global Outlook and Forecast 2021-2027
This report contains market size and forecasts of Glucagon Like Peptide-1 (GLP-1) Agonists in global, including the following market information:
Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Sales, 2016-2021, 2022-2027, (K Units)
Global top five Glucagon Like Peptide-1 (GLP-1) Agonists companies in 2020 (%)
The global Glucagon Like Peptide-1 (GLP-1) Agonists market was valued at 8007.2 million in 2020 and is projected to reach US$ 12930 million by 2027, at a CAGR of 12.7% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Glucagon Like Peptide-1 (GLP-1) Agonists manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Glucagon Like Peptide-1 (GLP-1) Agonists Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K Units)
Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Segment Percentages, By Type, 2020 (%)
Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Segment Percentages, By Application, 2020 (%)
Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Segment Percentages, By Region and Country, 2020 (%)
The report also provides analysis of leading market participants including:
Key companies Glucagon Like Peptide-1 (GLP-1) Agonists revenues in global market, 2016-2021 (Estimated), ($ millions)
Key companies Glucagon Like Peptide-1 (GLP-1) Agonists revenues share in global market, 2020 (%)
Key companies Glucagon Like Peptide-1 (GLP-1) Agonists sales in global market, 2016-2021 (Estimated), (K Units)
Key companies Glucagon Like Peptide-1 (GLP-1) Agonists sales share in global market, 2020 (%)
Further, the report presents profiles of competitors in the market, key players include:
Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Sales, 2016-2021, 2022-2027, (K Units)
Global top five Glucagon Like Peptide-1 (GLP-1) Agonists companies in 2020 (%)
The global Glucagon Like Peptide-1 (GLP-1) Agonists market was valued at 8007.2 million in 2020 and is projected to reach US$ 12930 million by 2027, at a CAGR of 12.7% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Glucagon Like Peptide-1 (GLP-1) Agonists manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Glucagon Like Peptide-1 (GLP-1) Agonists Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K Units)
Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Segment Percentages, By Type, 2020 (%)
- Exenatied
- Liraglutide
- Lixisenatide
- Albiglutide
- Dulaglutide
Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Segment Percentages, By Application, 2020 (%)
- Hospital
- Pharmacy
- Other
Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Segment Percentages, By Region and Country, 2020 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
The report also provides analysis of leading market participants including:
Key companies Glucagon Like Peptide-1 (GLP-1) Agonists revenues in global market, 2016-2021 (Estimated), ($ millions)
Key companies Glucagon Like Peptide-1 (GLP-1) Agonists revenues share in global market, 2020 (%)
Key companies Glucagon Like Peptide-1 (GLP-1) Agonists sales in global market, 2016-2021 (Estimated), (K Units)
Key companies Glucagon Like Peptide-1 (GLP-1) Agonists sales share in global market, 2020 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Novo Nordisk
- AstraZeneca
- Eli Lily
- GSK
- Sanofi
- Bristol-Myers Squibb
- Amylin
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS
1.1 Glucagon Like Peptide-1 (GLP-1) Agonists Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL GLUCAGON LIKE PEPTIDE-1 (GLP-1) AGONISTS OVERALL MARKET SIZE
2.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Size: 2021 VS 2027
2.2 Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue, Prospects & Forecasts: 2016-2027
2.3 Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales (Consumption): 2016-2027
3 COMPANY LANDSCAPE
3.1 Top Glucagon Like Peptide-1 (GLP-1) Agonists Players in Global Market
3.2 Top Global Glucagon Like Peptide-1 (GLP-1) Agonists Companies Ranked by Revenue
3.3 Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Companies
3.4 Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Companies
3.5 Global Glucagon Like Peptide-1 (GLP-1) Agonists Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Glucagon Like Peptide-1 (GLP-1) Agonists Companies in Global Market, by Revenue in 2020
3.7 Global Manufacturers Glucagon Like Peptide-1 (GLP-1) Agonists Product Type
3.8 Tier 1, Tier 2 and Tier 3 Glucagon Like Peptide-1 (GLP-1) Agonists Players in Global Market
3.8.1 List of Global Tier 1 Glucagon Like Peptide-1 (GLP-1) Agonists Companies
3.8.2 List of Global Tier 2 and Tier 3 Glucagon Like Peptide-1 (GLP-1) Agonists Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Size Markets, 2021 & 2027
4.1.2 Exenatied
4.1.3 Liraglutide
4.1.4 Lixisenatide
4.1.5 Albiglutide
4.1.6 Dulaglutide
4.2 By Type - Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue & Forecasts
4.2.1 By Type - Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue, 2016-2021
4.2.2 By Type - Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue, 2022-2027
4.2.3 By Type - Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share, 2016-2027
4.3 By Type - Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales & Forecasts
4.3.1 By Type - Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales, 2016-2021
4.3.2 By Type - Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales, 2022-2027
4.3.3 By Type - Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share, 2016-2027
4.4 By Type - Global Glucagon Like Peptide-1 (GLP-1) Agonists Price (Manufacturers Selling Prices), 2016-2027
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Size, 2021 & 2027
5.1.2 Hospital
5.1.3 Pharmacy
5.1.4 Other
5.2 By Application - Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue & Forecasts
5.2.1 By Application - Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue, 2016-2021
5.2.2 By Application - Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue, 2022-2027
5.2.3 By Application - Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share, 2016-2027
5.3 By Application - Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales & Forecasts
5.3.1 By Application - Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales, 2016-2021
5.3.2 By Application - Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales, 2022-2027
5.3.3 By Application - Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share, 2016-2027
5.4 By Application - Global Glucagon Like Peptide-1 (GLP-1) Agonists Price (Manufacturers Selling Prices), 2016-2027
6 SIGHTS BY REGION
6.1 By Region - Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Size, 2021 & 2027
6.2 By Region - Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue & Forecasts
6.2.1 By Region - Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue, 2016-2021
6.2.2 By Region - Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue, 2022-2027
6.2.3 By Region - Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share, 2016-2027
6.3 By Region - Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales & Forecasts
6.3.1 By Region - Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales, 2016-2021
6.3.2 By Region - Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales, 2022-2027
6.3.3 By Region - Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share, 2016-2027
6.4 North America
6.4.1 By Country - North America Glucagon Like Peptide-1 (GLP-1) Agonists Revenue, 2016-2027
6.4.2 By Country - North America Glucagon Like Peptide-1 (GLP-1) Agonists Sales, 2016-2027
6.4.3 US Glucagon Like Peptide-1 (GLP-1) Agonists Market Size, 2016-2027
6.4.4 Canada Glucagon Like Peptide-1 (GLP-1) Agonists Market Size, 2016-2027
6.4.5 Mexico Glucagon Like Peptide-1 (GLP-1) Agonists Market Size, 2016-2027
6.5 Europe
6.5.1 By Country - Europe Glucagon Like Peptide-1 (GLP-1) Agonists Revenue, 2016-2027
6.5.2 By Country - Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales, 2016-2027
6.5.3 Germany Glucagon Like Peptide-1 (GLP-1) Agonists Market Size, 2016-2027
6.5.4 France Glucagon Like Peptide-1 (GLP-1) Agonists Market Size, 2016-2027
6.5.5 U.K. Glucagon Like Peptide-1 (GLP-1) Agonists Market Size, 2016-2027
6.5.6 Italy Glucagon Like Peptide-1 (GLP-1) Agonists Market Size, 2016-2027
6.5.7 Russia Glucagon Like Peptide-1 (GLP-1) Agonists Market Size, 2016-2027
6.5.8 Nordic Countries Glucagon Like Peptide-1 (GLP-1) Agonists Market Size, 2016-2027
6.5.9 Benelux Glucagon Like Peptide-1 (GLP-1) Agonists Market Size, 2016-2027
6.6 Asia
6.6.1 By Region - Asia Glucagon Like Peptide-1 (GLP-1) Agonists Revenue, 2016-2027
6.6.2 By Region - Asia Glucagon Like Peptide-1 (GLP-1) Agonists Sales, 2016-2027
6.6.3 China Glucagon Like Peptide-1 (GLP-1) Agonists Market Size, 2016-2027
6.6.4 Japan Glucagon Like Peptide-1 (GLP-1) Agonists Market Size, 2016-2027
6.6.5 South Korea Glucagon Like Peptide-1 (GLP-1) Agonists Market Size, 2016-2027
6.6.6 Southeast Asia Glucagon Like Peptide-1 (GLP-1) Agonists Market Size, 2016-2027
6.6.7 India Glucagon Like Peptide-1 (GLP-1) Agonists Market Size, 2016-2027
6.7 South America
6.7.1 By Country - South America Glucagon Like Peptide-1 (GLP-1) Agonists Revenue, 2016-2027
6.7.2 By Country - South America Glucagon Like Peptide-1 (GLP-1) Agonists Sales, 2016-2027
6.7.3 Brazil Glucagon Like Peptide-1 (GLP-1) Agonists Market Size, 2016-2027
6.7.4 Argentina Glucagon Like Peptide-1 (GLP-1) Agonists Market Size, 2016-2027
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Glucagon Like Peptide-1 (GLP-1) Agonists Revenue, 2016-2027
6.8.2 By Country - Middle East & Africa Glucagon Like Peptide-1 (GLP-1) Agonists Sales, 2016-2027
6.8.3 Turkey Glucagon Like Peptide-1 (GLP-1) Agonists Market Size, 2016-2027
6.8.4 Israel Glucagon Like Peptide-1 (GLP-1) Agonists Market Size, 2016-2027
6.8.5 Saudi Arabia Glucagon Like Peptide-1 (GLP-1) Agonists Market Size, 2016-2027
6.8.6 UAE Glucagon Like Peptide-1 (GLP-1) Agonists Market Size, 2016-2027
7 MANUFACTURERS & BRANDS PROFILES
7.1 Novo Nordisk
7.1.1 Novo Nordisk Corporate Summary
7.1.2 Novo Nordisk Business Overview
7.1.3 Novo Nordisk Glucagon Like Peptide-1 (GLP-1) Agonists Major Product Offerings
7.1.4 Novo Nordisk Glucagon Like Peptide-1 (GLP-1) Agonists Sales and Revenue in Global (2016-2021)
7.1.5 Novo Nordisk Key News
7.2 AstraZeneca
7.2.1 AstraZeneca Corporate Summary
7.2.2 AstraZeneca Business Overview
7.2.3 AstraZeneca Glucagon Like Peptide-1 (GLP-1) Agonists Major Product Offerings
7.2.4 AstraZeneca Glucagon Like Peptide-1 (GLP-1) Agonists Sales and Revenue in Global (2016-2021)
7.2.5 AstraZeneca Key News
7.3 Eli Lily
7.3.1 Eli Lily Corporate Summary
7.3.2 Eli Lily Business Overview
7.3.3 Eli Lily Glucagon Like Peptide-1 (GLP-1) Agonists Major Product Offerings
7.3.4 Eli Lily Glucagon Like Peptide-1 (GLP-1) Agonists Sales and Revenue in Global (2016-2021)
7.3.5 Eli Lily Key News
7.4 GSK
7.4.1 GSK Corporate Summary
7.4.2 GSK Business Overview
7.4.3 GSK Glucagon Like Peptide-1 (GLP-1) Agonists Major Product Offerings
7.4.4 GSK Glucagon Like Peptide-1 (GLP-1) Agonists Sales and Revenue in Global (2016-2021)
7.4.5 GSK Key News
7.5 Sanofi
7.5.1 Sanofi Corporate Summary
7.5.2 Sanofi Business Overview
7.5.3 Sanofi Glucagon Like Peptide-1 (GLP-1) Agonists Major Product Offerings
7.5.4 Sanofi Glucagon Like Peptide-1 (GLP-1) Agonists Sales and Revenue in Global (2016-2021)
7.5.5 Sanofi Key News
7.6 Bristol-Myers Squibb
7.6.1 Bristol-Myers Squibb Corporate Summary
7.6.2 Bristol-Myers Squibb Business Overview
7.6.3 Bristol-Myers Squibb Glucagon Like Peptide-1 (GLP-1) Agonists Major Product Offerings
7.6.4 Bristol-Myers Squibb Glucagon Like Peptide-1 (GLP-1) Agonists Sales and Revenue in Global (2016-2021)
7.6.5 Bristol-Myers Squibb Key News
7.7 Amylin
7.7.1 Amylin Corporate Summary
7.7.2 Amylin Business Overview
7.7.3 Amylin Glucagon Like Peptide-1 (GLP-1) Agonists Major Product Offerings
7.4.4 Amylin Glucagon Like Peptide-1 (GLP-1) Agonists Sales and Revenue in Global (2016-2021)
7.7.5 Amylin Key News
8 GLOBAL GLUCAGON LIKE PEPTIDE-1 (GLP-1) AGONISTS PRODUCTION CAPACITY, ANALYSIS
8.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Production Capacity, 2016-2027
8.2 Glucagon Like Peptide-1 (GLP-1) Agonists Production Capacity of Key Manufacturers in Global Market
8.3 Global Glucagon Like Peptide-1 (GLP-1) Agonists Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 GLUCAGON LIKE PEPTIDE-1 (GLP-1) AGONISTS SUPPLY CHAIN ANALYSIS
10.1 Glucagon Like Peptide-1 (GLP-1) Agonists Industry Value Chain
10.2 Glucagon Like Peptide-1 (GLP-1) Agonists Upstream Market
10.3 Glucagon Like Peptide-1 (GLP-1) Agonists Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Glucagon Like Peptide-1 (GLP-1) Agonists Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
1.1 Glucagon Like Peptide-1 (GLP-1) Agonists Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL GLUCAGON LIKE PEPTIDE-1 (GLP-1) AGONISTS OVERALL MARKET SIZE
2.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Size: 2021 VS 2027
2.2 Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue, Prospects & Forecasts: 2016-2027
2.3 Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales (Consumption): 2016-2027
3 COMPANY LANDSCAPE
3.1 Top Glucagon Like Peptide-1 (GLP-1) Agonists Players in Global Market
3.2 Top Global Glucagon Like Peptide-1 (GLP-1) Agonists Companies Ranked by Revenue
3.3 Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Companies
3.4 Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Companies
3.5 Global Glucagon Like Peptide-1 (GLP-1) Agonists Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Glucagon Like Peptide-1 (GLP-1) Agonists Companies in Global Market, by Revenue in 2020
3.7 Global Manufacturers Glucagon Like Peptide-1 (GLP-1) Agonists Product Type
3.8 Tier 1, Tier 2 and Tier 3 Glucagon Like Peptide-1 (GLP-1) Agonists Players in Global Market
3.8.1 List of Global Tier 1 Glucagon Like Peptide-1 (GLP-1) Agonists Companies
3.8.2 List of Global Tier 2 and Tier 3 Glucagon Like Peptide-1 (GLP-1) Agonists Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Size Markets, 2021 & 2027
4.1.2 Exenatied
4.1.3 Liraglutide
4.1.4 Lixisenatide
4.1.5 Albiglutide
4.1.6 Dulaglutide
4.2 By Type - Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue & Forecasts
4.2.1 By Type - Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue, 2016-2021
4.2.2 By Type - Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue, 2022-2027
4.2.3 By Type - Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share, 2016-2027
4.3 By Type - Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales & Forecasts
4.3.1 By Type - Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales, 2016-2021
4.3.2 By Type - Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales, 2022-2027
4.3.3 By Type - Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share, 2016-2027
4.4 By Type - Global Glucagon Like Peptide-1 (GLP-1) Agonists Price (Manufacturers Selling Prices), 2016-2027
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Size, 2021 & 2027
5.1.2 Hospital
5.1.3 Pharmacy
5.1.4 Other
5.2 By Application - Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue & Forecasts
5.2.1 By Application - Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue, 2016-2021
5.2.2 By Application - Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue, 2022-2027
5.2.3 By Application - Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share, 2016-2027
5.3 By Application - Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales & Forecasts
5.3.1 By Application - Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales, 2016-2021
5.3.2 By Application - Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales, 2022-2027
5.3.3 By Application - Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share, 2016-2027
5.4 By Application - Global Glucagon Like Peptide-1 (GLP-1) Agonists Price (Manufacturers Selling Prices), 2016-2027
6 SIGHTS BY REGION
6.1 By Region - Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Size, 2021 & 2027
6.2 By Region - Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue & Forecasts
6.2.1 By Region - Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue, 2016-2021
6.2.2 By Region - Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue, 2022-2027
6.2.3 By Region - Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share, 2016-2027
6.3 By Region - Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales & Forecasts
6.3.1 By Region - Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales, 2016-2021
6.3.2 By Region - Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales, 2022-2027
6.3.3 By Region - Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share, 2016-2027
6.4 North America
6.4.1 By Country - North America Glucagon Like Peptide-1 (GLP-1) Agonists Revenue, 2016-2027
6.4.2 By Country - North America Glucagon Like Peptide-1 (GLP-1) Agonists Sales, 2016-2027
6.4.3 US Glucagon Like Peptide-1 (GLP-1) Agonists Market Size, 2016-2027
6.4.4 Canada Glucagon Like Peptide-1 (GLP-1) Agonists Market Size, 2016-2027
6.4.5 Mexico Glucagon Like Peptide-1 (GLP-1) Agonists Market Size, 2016-2027
6.5 Europe
6.5.1 By Country - Europe Glucagon Like Peptide-1 (GLP-1) Agonists Revenue, 2016-2027
6.5.2 By Country - Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales, 2016-2027
6.5.3 Germany Glucagon Like Peptide-1 (GLP-1) Agonists Market Size, 2016-2027
6.5.4 France Glucagon Like Peptide-1 (GLP-1) Agonists Market Size, 2016-2027
6.5.5 U.K. Glucagon Like Peptide-1 (GLP-1) Agonists Market Size, 2016-2027
6.5.6 Italy Glucagon Like Peptide-1 (GLP-1) Agonists Market Size, 2016-2027
6.5.7 Russia Glucagon Like Peptide-1 (GLP-1) Agonists Market Size, 2016-2027
6.5.8 Nordic Countries Glucagon Like Peptide-1 (GLP-1) Agonists Market Size, 2016-2027
6.5.9 Benelux Glucagon Like Peptide-1 (GLP-1) Agonists Market Size, 2016-2027
6.6 Asia
6.6.1 By Region - Asia Glucagon Like Peptide-1 (GLP-1) Agonists Revenue, 2016-2027
6.6.2 By Region - Asia Glucagon Like Peptide-1 (GLP-1) Agonists Sales, 2016-2027
6.6.3 China Glucagon Like Peptide-1 (GLP-1) Agonists Market Size, 2016-2027
6.6.4 Japan Glucagon Like Peptide-1 (GLP-1) Agonists Market Size, 2016-2027
6.6.5 South Korea Glucagon Like Peptide-1 (GLP-1) Agonists Market Size, 2016-2027
6.6.6 Southeast Asia Glucagon Like Peptide-1 (GLP-1) Agonists Market Size, 2016-2027
6.6.7 India Glucagon Like Peptide-1 (GLP-1) Agonists Market Size, 2016-2027
6.7 South America
6.7.1 By Country - South America Glucagon Like Peptide-1 (GLP-1) Agonists Revenue, 2016-2027
6.7.2 By Country - South America Glucagon Like Peptide-1 (GLP-1) Agonists Sales, 2016-2027
6.7.3 Brazil Glucagon Like Peptide-1 (GLP-1) Agonists Market Size, 2016-2027
6.7.4 Argentina Glucagon Like Peptide-1 (GLP-1) Agonists Market Size, 2016-2027
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Glucagon Like Peptide-1 (GLP-1) Agonists Revenue, 2016-2027
6.8.2 By Country - Middle East & Africa Glucagon Like Peptide-1 (GLP-1) Agonists Sales, 2016-2027
6.8.3 Turkey Glucagon Like Peptide-1 (GLP-1) Agonists Market Size, 2016-2027
6.8.4 Israel Glucagon Like Peptide-1 (GLP-1) Agonists Market Size, 2016-2027
6.8.5 Saudi Arabia Glucagon Like Peptide-1 (GLP-1) Agonists Market Size, 2016-2027
6.8.6 UAE Glucagon Like Peptide-1 (GLP-1) Agonists Market Size, 2016-2027
7 MANUFACTURERS & BRANDS PROFILES
7.1 Novo Nordisk
7.1.1 Novo Nordisk Corporate Summary
7.1.2 Novo Nordisk Business Overview
7.1.3 Novo Nordisk Glucagon Like Peptide-1 (GLP-1) Agonists Major Product Offerings
7.1.4 Novo Nordisk Glucagon Like Peptide-1 (GLP-1) Agonists Sales and Revenue in Global (2016-2021)
7.1.5 Novo Nordisk Key News
7.2 AstraZeneca
7.2.1 AstraZeneca Corporate Summary
7.2.2 AstraZeneca Business Overview
7.2.3 AstraZeneca Glucagon Like Peptide-1 (GLP-1) Agonists Major Product Offerings
7.2.4 AstraZeneca Glucagon Like Peptide-1 (GLP-1) Agonists Sales and Revenue in Global (2016-2021)
7.2.5 AstraZeneca Key News
7.3 Eli Lily
7.3.1 Eli Lily Corporate Summary
7.3.2 Eli Lily Business Overview
7.3.3 Eli Lily Glucagon Like Peptide-1 (GLP-1) Agonists Major Product Offerings
7.3.4 Eli Lily Glucagon Like Peptide-1 (GLP-1) Agonists Sales and Revenue in Global (2016-2021)
7.3.5 Eli Lily Key News
7.4 GSK
7.4.1 GSK Corporate Summary
7.4.2 GSK Business Overview
7.4.3 GSK Glucagon Like Peptide-1 (GLP-1) Agonists Major Product Offerings
7.4.4 GSK Glucagon Like Peptide-1 (GLP-1) Agonists Sales and Revenue in Global (2016-2021)
7.4.5 GSK Key News
7.5 Sanofi
7.5.1 Sanofi Corporate Summary
7.5.2 Sanofi Business Overview
7.5.3 Sanofi Glucagon Like Peptide-1 (GLP-1) Agonists Major Product Offerings
7.5.4 Sanofi Glucagon Like Peptide-1 (GLP-1) Agonists Sales and Revenue in Global (2016-2021)
7.5.5 Sanofi Key News
7.6 Bristol-Myers Squibb
7.6.1 Bristol-Myers Squibb Corporate Summary
7.6.2 Bristol-Myers Squibb Business Overview
7.6.3 Bristol-Myers Squibb Glucagon Like Peptide-1 (GLP-1) Agonists Major Product Offerings
7.6.4 Bristol-Myers Squibb Glucagon Like Peptide-1 (GLP-1) Agonists Sales and Revenue in Global (2016-2021)
7.6.5 Bristol-Myers Squibb Key News
7.7 Amylin
7.7.1 Amylin Corporate Summary
7.7.2 Amylin Business Overview
7.7.3 Amylin Glucagon Like Peptide-1 (GLP-1) Agonists Major Product Offerings
7.4.4 Amylin Glucagon Like Peptide-1 (GLP-1) Agonists Sales and Revenue in Global (2016-2021)
7.7.5 Amylin Key News
8 GLOBAL GLUCAGON LIKE PEPTIDE-1 (GLP-1) AGONISTS PRODUCTION CAPACITY, ANALYSIS
8.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Production Capacity, 2016-2027
8.2 Glucagon Like Peptide-1 (GLP-1) Agonists Production Capacity of Key Manufacturers in Global Market
8.3 Global Glucagon Like Peptide-1 (GLP-1) Agonists Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 GLUCAGON LIKE PEPTIDE-1 (GLP-1) AGONISTS SUPPLY CHAIN ANALYSIS
10.1 Glucagon Like Peptide-1 (GLP-1) Agonists Industry Value Chain
10.2 Glucagon Like Peptide-1 (GLP-1) Agonists Upstream Market
10.3 Glucagon Like Peptide-1 (GLP-1) Agonists Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Glucagon Like Peptide-1 (GLP-1) Agonists Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES
Table 1. Key Players of Glucagon Like Peptide-1 (GLP-1) Agonists in Global Market
Table 2. Top Glucagon Like Peptide-1 (GLP-1) Agonists Players in Global Market, Ranking by Revenue (2019)
Table 3. Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Companies, (US$, Mn), 2016-2021
Table 4. Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Share by Companies, 2016-2021
Table 5. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Companies, (K Units), 2016-2021
Table 6. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Glucagon Like Peptide-1 (GLP-1) Agonists Price (2016-2021) & (USD/Unit)
Table 8. Global Manufacturers Glucagon Like Peptide-1 (GLP-1) Agonists Product Type
Table 9. List of Global Tier 1 Glucagon Like Peptide-1 (GLP-1) Agonists Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Glucagon Like Peptide-1 (GLP-1) Agonists Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type – Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (US$, Mn), 2016-2021
Table 13. By Type - Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (US$, Mn), 2022-2027
Table 14. By Type - Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units), 2016-2021
Table 15. By Type - Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units), 2022-2027
Table 16. By Application – Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue, (US$, Mn), 2021 VS 2027
Table 17. By Application - Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (US$, Mn), 2016-2021
Table 18. By Application - Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (US$, Mn), 2022-2027
Table 19. By Application - Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units), 2016-2021
Table 20. By Application - Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units), 2022-2027
Table 21. By Region – Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue, (US$, Mn), 2021 VS 2027
Table 22. By Region - Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (US$, Mn), 2016-2021
Table 23. By Region - Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (US$, Mn), 2022-2027
Table 24. By Region - Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units), 2016-2021
Table 25. By Region - Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units), 2022-2027
Table 26. By Country - North America Glucagon Like Peptide-1 (GLP-1) Agonists Revenue, (US$, Mn), 2016-2021
Table 27. By Country - North America Glucagon Like Peptide-1 (GLP-1) Agonists Revenue, (US$, Mn), 2022-2027
Table 28. By Country - North America Glucagon Like Peptide-1 (GLP-1) Agonists Sales, (K Units), 2016-2021
Table 29. By Country - North America Glucagon Like Peptide-1 (GLP-1) Agonists Sales, (K Units), 2022-2027
Table 30. By Country - Europe Glucagon Like Peptide-1 (GLP-1) Agonists Revenue, (US$, Mn), 2016-2021
Table 31. By Country - Europe Glucagon Like Peptide-1 (GLP-1) Agonists Revenue, (US$, Mn), 2022-2027
Table 32. By Country - Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales, (K Units), 2016-2021
Table 33. By Country - Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales, (K Units), 2022-2027
Table 34. By Region - Asia Glucagon Like Peptide-1 (GLP-1) Agonists Revenue, (US$, Mn), 2016-2021
Table 35. By Region - Asia Glucagon Like Peptide-1 (GLP-1) Agonists Revenue, (US$, Mn), 2022-2027
Table 36. By Region - Asia Glucagon Like Peptide-1 (GLP-1) Agonists Sales, (K Units), 2016-2021
Table 37. By Region - Asia Glucagon Like Peptide-1 (GLP-1) Agonists Sales, (K Units), 2022-2027
Table 38. By Country - South America Glucagon Like Peptide-1 (GLP-1) Agonists Revenue, (US$, Mn), 2016-2021
Table 39. By Country - South America Glucagon Like Peptide-1 (GLP-1) Agonists Revenue, (US$, Mn), 2022-2027
Table 40. By Country - South America Glucagon Like Peptide-1 (GLP-1) Agonists Sales, (K Units), 2016-2021
Table 41. By Country - South America Glucagon Like Peptide-1 (GLP-1) Agonists Sales, (K Units), 2022-2027
Table 42. By Country - Middle East & Africa Glucagon Like Peptide-1 (GLP-1) Agonists Revenue, (US$, Mn), 2016-2021
Table 43. By Country - Middle East & Africa Glucagon Like Peptide-1 (GLP-1) Agonists Revenue, (US$, Mn), 2022-2027
Table 44. By Country - Middle East & Africa Glucagon Like Peptide-1 (GLP-1) Agonists Sales, (K Units), 2016-2021
Table 45. By Country - Middle East & Africa Glucagon Like Peptide-1 (GLP-1) Agonists Sales, (K Units), 2022-2027
Table 46. Novo Nordisk Corporate Summary
Table 47. Novo Nordisk Glucagon Like Peptide-1 (GLP-1) Agonists Product Offerings
Table 48. Novo Nordisk Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 49. AstraZeneca Corporate Summary
Table 50. AstraZeneca Glucagon Like Peptide-1 (GLP-1) Agonists Product Offerings
Table 51. AstraZeneca Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 52. Eli Lily Corporate Summary
Table 53. Eli Lily Glucagon Like Peptide-1 (GLP-1) Agonists Product Offerings
Table 54. Eli Lily Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 55. GSK Corporate Summary
Table 56. GSK Glucagon Like Peptide-1 (GLP-1) Agonists Product Offerings
Table 57. GSK Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 58. Sanofi Corporate Summary
Table 59. Sanofi Glucagon Like Peptide-1 (GLP-1) Agonists Product Offerings
Table 60. Sanofi Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 61. Bristol-Myers Squibb Corporate Summary
Table 62. Bristol-Myers Squibb Glucagon Like Peptide-1 (GLP-1) Agonists Product Offerings
Table 63. Bristol-Myers Squibb Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 64. Amylin Corporate Summary
Table 65. Amylin Glucagon Like Peptide-1 (GLP-1) Agonists Product Offerings
Table 66. Amylin Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 67. Glucagon Like Peptide-1 (GLP-1) Agonists Production Capacity (K Units) of Key Manufacturers in Global Market, 2019-2021 (K Units)
Table 68. Global Glucagon Like Peptide-1 (GLP-1) Agonists Capacity Market Share of Key Manufacturers, 2019-2021
Table 69. Global Glucagon Like Peptide-1 (GLP-1) Agonists Production by Region, 2016-2021 (K Units)
Table 70. Global Glucagon Like Peptide-1 (GLP-1) Agonists Production by Region, 2022-2027 (K Units)
Table 71. Glucagon Like Peptide-1 (GLP-1) Agonists Market Opportunities & Trends in Global Market
Table 72. Glucagon Like Peptide-1 (GLP-1) Agonists Market Drivers in Global Market
Table 73. Glucagon Like Peptide-1 (GLP-1) Agonists Market Restraints in Global Market
Table 74. Glucagon Like Peptide-1 (GLP-1) Agonists Raw Materials
Table 75. Glucagon Like Peptide-1 (GLP-1) Agonists Raw Materials Suppliers in Global Market
Table 76. Typical Glucagon Like Peptide-1 (GLP-1) Agonists Downstream
Table 77. Glucagon Like Peptide-1 (GLP-1) Agonists Downstream Clients in Global Market
Table 78. Glucagon Like Peptide-1 (GLP-1) Agonists Distributors and Sales Agents in Global Market
Table 1. Key Players of Glucagon Like Peptide-1 (GLP-1) Agonists in Global Market
Table 2. Top Glucagon Like Peptide-1 (GLP-1) Agonists Players in Global Market, Ranking by Revenue (2019)
Table 3. Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Companies, (US$, Mn), 2016-2021
Table 4. Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Share by Companies, 2016-2021
Table 5. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Companies, (K Units), 2016-2021
Table 6. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Glucagon Like Peptide-1 (GLP-1) Agonists Price (2016-2021) & (USD/Unit)
Table 8. Global Manufacturers Glucagon Like Peptide-1 (GLP-1) Agonists Product Type
Table 9. List of Global Tier 1 Glucagon Like Peptide-1 (GLP-1) Agonists Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Glucagon Like Peptide-1 (GLP-1) Agonists Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type – Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (US$, Mn), 2016-2021
Table 13. By Type - Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (US$, Mn), 2022-2027
Table 14. By Type - Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units), 2016-2021
Table 15. By Type - Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units), 2022-2027
Table 16. By Application – Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue, (US$, Mn), 2021 VS 2027
Table 17. By Application - Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (US$, Mn), 2016-2021
Table 18. By Application - Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (US$, Mn), 2022-2027
Table 19. By Application - Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units), 2016-2021
Table 20. By Application - Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units), 2022-2027
Table 21. By Region – Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue, (US$, Mn), 2021 VS 2027
Table 22. By Region - Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (US$, Mn), 2016-2021
Table 23. By Region - Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (US$, Mn), 2022-2027
Table 24. By Region - Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units), 2016-2021
Table 25. By Region - Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units), 2022-2027
Table 26. By Country - North America Glucagon Like Peptide-1 (GLP-1) Agonists Revenue, (US$, Mn), 2016-2021
Table 27. By Country - North America Glucagon Like Peptide-1 (GLP-1) Agonists Revenue, (US$, Mn), 2022-2027
Table 28. By Country - North America Glucagon Like Peptide-1 (GLP-1) Agonists Sales, (K Units), 2016-2021
Table 29. By Country - North America Glucagon Like Peptide-1 (GLP-1) Agonists Sales, (K Units), 2022-2027
Table 30. By Country - Europe Glucagon Like Peptide-1 (GLP-1) Agonists Revenue, (US$, Mn), 2016-2021
Table 31. By Country - Europe Glucagon Like Peptide-1 (GLP-1) Agonists Revenue, (US$, Mn), 2022-2027
Table 32. By Country - Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales, (K Units), 2016-2021
Table 33. By Country - Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales, (K Units), 2022-2027
Table 34. By Region - Asia Glucagon Like Peptide-1 (GLP-1) Agonists Revenue, (US$, Mn), 2016-2021
Table 35. By Region - Asia Glucagon Like Peptide-1 (GLP-1) Agonists Revenue, (US$, Mn), 2022-2027
Table 36. By Region - Asia Glucagon Like Peptide-1 (GLP-1) Agonists Sales, (K Units), 2016-2021
Table 37. By Region - Asia Glucagon Like Peptide-1 (GLP-1) Agonists Sales, (K Units), 2022-2027
Table 38. By Country - South America Glucagon Like Peptide-1 (GLP-1) Agonists Revenue, (US$, Mn), 2016-2021
Table 39. By Country - South America Glucagon Like Peptide-1 (GLP-1) Agonists Revenue, (US$, Mn), 2022-2027
Table 40. By Country - South America Glucagon Like Peptide-1 (GLP-1) Agonists Sales, (K Units), 2016-2021
Table 41. By Country - South America Glucagon Like Peptide-1 (GLP-1) Agonists Sales, (K Units), 2022-2027
Table 42. By Country - Middle East & Africa Glucagon Like Peptide-1 (GLP-1) Agonists Revenue, (US$, Mn), 2016-2021
Table 43. By Country - Middle East & Africa Glucagon Like Peptide-1 (GLP-1) Agonists Revenue, (US$, Mn), 2022-2027
Table 44. By Country - Middle East & Africa Glucagon Like Peptide-1 (GLP-1) Agonists Sales, (K Units), 2016-2021
Table 45. By Country - Middle East & Africa Glucagon Like Peptide-1 (GLP-1) Agonists Sales, (K Units), 2022-2027
Table 46. Novo Nordisk Corporate Summary
Table 47. Novo Nordisk Glucagon Like Peptide-1 (GLP-1) Agonists Product Offerings
Table 48. Novo Nordisk Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 49. AstraZeneca Corporate Summary
Table 50. AstraZeneca Glucagon Like Peptide-1 (GLP-1) Agonists Product Offerings
Table 51. AstraZeneca Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 52. Eli Lily Corporate Summary
Table 53. Eli Lily Glucagon Like Peptide-1 (GLP-1) Agonists Product Offerings
Table 54. Eli Lily Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 55. GSK Corporate Summary
Table 56. GSK Glucagon Like Peptide-1 (GLP-1) Agonists Product Offerings
Table 57. GSK Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 58. Sanofi Corporate Summary
Table 59. Sanofi Glucagon Like Peptide-1 (GLP-1) Agonists Product Offerings
Table 60. Sanofi Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 61. Bristol-Myers Squibb Corporate Summary
Table 62. Bristol-Myers Squibb Glucagon Like Peptide-1 (GLP-1) Agonists Product Offerings
Table 63. Bristol-Myers Squibb Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 64. Amylin Corporate Summary
Table 65. Amylin Glucagon Like Peptide-1 (GLP-1) Agonists Product Offerings
Table 66. Amylin Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 67. Glucagon Like Peptide-1 (GLP-1) Agonists Production Capacity (K Units) of Key Manufacturers in Global Market, 2019-2021 (K Units)
Table 68. Global Glucagon Like Peptide-1 (GLP-1) Agonists Capacity Market Share of Key Manufacturers, 2019-2021
Table 69. Global Glucagon Like Peptide-1 (GLP-1) Agonists Production by Region, 2016-2021 (K Units)
Table 70. Global Glucagon Like Peptide-1 (GLP-1) Agonists Production by Region, 2022-2027 (K Units)
Table 71. Glucagon Like Peptide-1 (GLP-1) Agonists Market Opportunities & Trends in Global Market
Table 72. Glucagon Like Peptide-1 (GLP-1) Agonists Market Drivers in Global Market
Table 73. Glucagon Like Peptide-1 (GLP-1) Agonists Market Restraints in Global Market
Table 74. Glucagon Like Peptide-1 (GLP-1) Agonists Raw Materials
Table 75. Glucagon Like Peptide-1 (GLP-1) Agonists Raw Materials Suppliers in Global Market
Table 76. Typical Glucagon Like Peptide-1 (GLP-1) Agonists Downstream
Table 77. Glucagon Like Peptide-1 (GLP-1) Agonists Downstream Clients in Global Market
Table 78. Glucagon Like Peptide-1 (GLP-1) Agonists Distributors and Sales Agents in Global Market
LIST OF FIGURES
Figure 1. Glucagon Like Peptide-1 (GLP-1) Agonists Segment by Type
Figure 2. Glucagon Like Peptide-1 (GLP-1) Agonists Segment by Application
Figure 3. Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue, 2016-2027 (US$, Mn)
Figure 7. Glucagon Like Peptide-1 (GLP-1) Agonists Sales in Global Market: 2016-2027 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Glucagon Like Peptide-1 (GLP-1) Agonists Revenue in 2020
Figure 9. By Type - Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share, 2016-2027
Figure 10. By Type - Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share, 2016-2027
Figure 11. By Type - Global Glucagon Like Peptide-1 (GLP-1) Agonists Price (USD/Unit), 2016-2027
Figure 12. By Application - Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share, 2016-2027
Figure 13. By Application - Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share, 2016-2027
Figure 14. By Application - Global Glucagon Like Peptide-1 (GLP-1) Agonists Price (USD/Unit), 2016-2027
Figure 15. By Region - Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share, 2016-2027
Figure 16. By Region - Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share, 2016-2027
Figure 17. By Country - North America Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share, 2016-2027
Figure 18. By Country - North America Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share, 2016-2027
Figure 19. US Glucagon Like Peptide-1 (GLP-1) Agonists Revenue, (US$, Mn), 2016-2027
Figure 20. Canada Glucagon Like Peptide-1 (GLP-1) Agonists Revenue, (US$, Mn), 2016-2027
Figure 21. Mexico Glucagon Like Peptide-1 (GLP-1) Agonists Revenue, (US$, Mn), 2016-2027
Figure 22. By Country - Europe Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share, 2016-2027
Figure 23. By Country - Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share, 2016-2027
Figure 24. Germany Glucagon Like Peptide-1 (GLP-1) Agonists Revenue, (US$, Mn), 2016-2027
Figure 25. France Glucagon Like Peptide-1 (GLP-1) Agonists Revenue, (US$, Mn), 2016-2027
Figure 26. U.K. Glucagon Like Peptide-1 (GLP-1) Agonists Revenue, (US$, Mn), 2016-2027
Figure 27. Italy Glucagon Like Peptide-1 (GLP-1) Agonists Revenue, (US$, Mn), 2016-2027
Figure 28. Russia Glucagon Like Peptide-1 (GLP-1) Agonists Revenue, (US$, Mn), 2016-2027
Figure 29. Nordic Countries Glucagon Like Peptide-1 (GLP-1) Agonists Revenue, (US$, Mn), 2016-2027
Figure 30. Benelux Glucagon Like Peptide-1 (GLP-1) Agonists Revenue, (US$, Mn), 2016-2027
Figure 31. By Region - Asia Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share, 2016-2027
Figure 32. By Region - Asia Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share, 2016-2027
Figure 33. China Glucagon Like Peptide-1 (GLP-1) Agonists Revenue, (US$, Mn), 2016-2027
Figure 34. Japan Glucagon Like Peptide-1 (GLP-1) Agonists Revenue, (US$, Mn), 2016-2027
Figure 35. South Korea Glucagon Like Peptide-1 (GLP-1) Agonists Revenue, (US$, Mn), 2016-2027
Figure 36. Southeast Asia Glucagon Like Peptide-1 (GLP-1) Agonists Revenue, (US$, Mn), 2016-2027
Figure 37. India Glucagon Like Peptide-1 (GLP-1) Agonists Revenue, (US$, Mn), 2016-2027
Figure 38. By Country - South America Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share, 2016-2027
Figure 39. By Country - South America Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share, 2016-2027
Figure 40. Brazil Glucagon Like Peptide-1 (GLP-1) Agonists Revenue, (US$, Mn), 2016-2027
Figure 41. Argentina Glucagon Like Peptide-1 (GLP-1) Agonists Revenue, (US$, Mn), 2016-2027
Figure 42. By Country - Middle East & Africa Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share, 2016-2027
Figure 43. By Country - Middle East & Africa Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share, 2016-2027
Figure 44. Turkey Glucagon Like Peptide-1 (GLP-1) Agonists Revenue, (US$, Mn), 2016-2027
Figure 45. Israel Glucagon Like Peptide-1 (GLP-1) Agonists Revenue, (US$, Mn), 2016-2027
Figure 46. Saudi Arabia Glucagon Like Peptide-1 (GLP-1) Agonists Revenue, (US$, Mn), 2016-2027
Figure 47. UAE Glucagon Like Peptide-1 (GLP-1) Agonists Revenue, (US$, Mn), 2016-2027
Figure 48. Global Glucagon Like Peptide-1 (GLP-1) Agonists Production Capacity (K Units), 2016-2027
Figure 49. The Percentage of Production Glucagon Like Peptide-1 (GLP-1) Agonists by Region, 2020 VS 2027
Figure 50. Glucagon Like Peptide-1 (GLP-1) Agonists Industry Value Chain
Figure 51. Marketing Channels
Figure 1. Glucagon Like Peptide-1 (GLP-1) Agonists Segment by Type
Figure 2. Glucagon Like Peptide-1 (GLP-1) Agonists Segment by Application
Figure 3. Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue, 2016-2027 (US$, Mn)
Figure 7. Glucagon Like Peptide-1 (GLP-1) Agonists Sales in Global Market: 2016-2027 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Glucagon Like Peptide-1 (GLP-1) Agonists Revenue in 2020
Figure 9. By Type - Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share, 2016-2027
Figure 10. By Type - Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share, 2016-2027
Figure 11. By Type - Global Glucagon Like Peptide-1 (GLP-1) Agonists Price (USD/Unit), 2016-2027
Figure 12. By Application - Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share, 2016-2027
Figure 13. By Application - Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share, 2016-2027
Figure 14. By Application - Global Glucagon Like Peptide-1 (GLP-1) Agonists Price (USD/Unit), 2016-2027
Figure 15. By Region - Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share, 2016-2027
Figure 16. By Region - Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share, 2016-2027
Figure 17. By Country - North America Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share, 2016-2027
Figure 18. By Country - North America Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share, 2016-2027
Figure 19. US Glucagon Like Peptide-1 (GLP-1) Agonists Revenue, (US$, Mn), 2016-2027
Figure 20. Canada Glucagon Like Peptide-1 (GLP-1) Agonists Revenue, (US$, Mn), 2016-2027
Figure 21. Mexico Glucagon Like Peptide-1 (GLP-1) Agonists Revenue, (US$, Mn), 2016-2027
Figure 22. By Country - Europe Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share, 2016-2027
Figure 23. By Country - Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share, 2016-2027
Figure 24. Germany Glucagon Like Peptide-1 (GLP-1) Agonists Revenue, (US$, Mn), 2016-2027
Figure 25. France Glucagon Like Peptide-1 (GLP-1) Agonists Revenue, (US$, Mn), 2016-2027
Figure 26. U.K. Glucagon Like Peptide-1 (GLP-1) Agonists Revenue, (US$, Mn), 2016-2027
Figure 27. Italy Glucagon Like Peptide-1 (GLP-1) Agonists Revenue, (US$, Mn), 2016-2027
Figure 28. Russia Glucagon Like Peptide-1 (GLP-1) Agonists Revenue, (US$, Mn), 2016-2027
Figure 29. Nordic Countries Glucagon Like Peptide-1 (GLP-1) Agonists Revenue, (US$, Mn), 2016-2027
Figure 30. Benelux Glucagon Like Peptide-1 (GLP-1) Agonists Revenue, (US$, Mn), 2016-2027
Figure 31. By Region - Asia Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share, 2016-2027
Figure 32. By Region - Asia Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share, 2016-2027
Figure 33. China Glucagon Like Peptide-1 (GLP-1) Agonists Revenue, (US$, Mn), 2016-2027
Figure 34. Japan Glucagon Like Peptide-1 (GLP-1) Agonists Revenue, (US$, Mn), 2016-2027
Figure 35. South Korea Glucagon Like Peptide-1 (GLP-1) Agonists Revenue, (US$, Mn), 2016-2027
Figure 36. Southeast Asia Glucagon Like Peptide-1 (GLP-1) Agonists Revenue, (US$, Mn), 2016-2027
Figure 37. India Glucagon Like Peptide-1 (GLP-1) Agonists Revenue, (US$, Mn), 2016-2027
Figure 38. By Country - South America Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share, 2016-2027
Figure 39. By Country - South America Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share, 2016-2027
Figure 40. Brazil Glucagon Like Peptide-1 (GLP-1) Agonists Revenue, (US$, Mn), 2016-2027
Figure 41. Argentina Glucagon Like Peptide-1 (GLP-1) Agonists Revenue, (US$, Mn), 2016-2027
Figure 42. By Country - Middle East & Africa Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share, 2016-2027
Figure 43. By Country - Middle East & Africa Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share, 2016-2027
Figure 44. Turkey Glucagon Like Peptide-1 (GLP-1) Agonists Revenue, (US$, Mn), 2016-2027
Figure 45. Israel Glucagon Like Peptide-1 (GLP-1) Agonists Revenue, (US$, Mn), 2016-2027
Figure 46. Saudi Arabia Glucagon Like Peptide-1 (GLP-1) Agonists Revenue, (US$, Mn), 2016-2027
Figure 47. UAE Glucagon Like Peptide-1 (GLP-1) Agonists Revenue, (US$, Mn), 2016-2027
Figure 48. Global Glucagon Like Peptide-1 (GLP-1) Agonists Production Capacity (K Units), 2016-2027
Figure 49. The Percentage of Production Glucagon Like Peptide-1 (GLP-1) Agonists by Region, 2020 VS 2027
Figure 50. Glucagon Like Peptide-1 (GLP-1) Agonists Industry Value Chain
Figure 51. Marketing Channels
